SCHEMBL5560965

SCHEMBL5560965

COc1ccc2c(c1)OC(C(C)C)C(=O)N(Cc1c(F)cccc1F)C2C(=O)Nc1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 6/20 0.38
RAB9A P51151 3/20 0.38
NPC1 O15118 3/20 0.38
GNRHR P30968 3/20 0.38
NFKB1 P19838 1/20 0.37
NFKB2 Q00653 1/20 0.37
RELA Q04206 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
PDE7A Q13946 1/20 0.37
ALDH1A1 P00352 2/20 0.36
MEN1 O00255 1/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
MAPK1 P28482 1/20 0.36
KMT2A Q03164 1/20 0.36
KCNA5 P22460 1/20 0.36
KCNH2 Q12809 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TSHR P16473 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5561606 0.89 NPC1 (0.36) RAB9ANPC1PDE7AALDH1A1MEN1
SCHEMBL6027038 0.89 GNRHR (0.39) GNRHRALDH1A1MEN1LMNAMAPT
SCHEMBL5561059 0.87 KCNA5 (0.46) GNRHRNFKB1NFKB2RELAALDH1A1
SCHEMBL5563683 0.86 PTGER3 (0.42) RORCALDH1A1MEN1MAPTMAPK1
SCHEMBL5556632 0.86 MAPT (0.40) RAB9ANPC1NFKB1NFKB2RELA
SCHEMBL5563041 0.86 GAA (0.39) RAB9ANPC1NFKB1NFKB2RELA
SCHEMBL5560963 0.85 F2 (0.48) RAB9ANPC1GNRHRALDH1A1MEN1
SCHEMBL5561610 0.85 ALDH1A1 (0.37) RAB9ANPC1PDE7AALDH1A1MEN1
SCHEMBL5561387 0.85 GAA (0.40) RAB9ANPC1NFKB1NFKB2RELA
SCHEMBL5562092 0.84 LMNA (0.34) RAB9ANPC1PDE7AALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1631296-B1 2,3,4,5-TETRAHYDROBENZO¬F|¬1,4|OXAZEPINE-5-CARBOXYLIC ACID AMIDE DERIVATIVES AS GAMMA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE HOFFMANN LA ROCHE (CH) 2007-04-25 EP disclosed